Tudor Investment Corp
ANIP icon

Tudor Investment Corp’s ANI Pharmaceuticals ANIP Stock Holding History

Tudor Investment Corp’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,509
Closed -$435K – 3562
2025
Q4 		$435K Sell
5,509
-6,341
-54% -$549K ﹤0.01% 2790
2025
Q3 		$1.09M Buy
+11,850
New +$966K ﹤0.01% 2206
2025
Q2 		– Sell
-10,856
Closed -$727K – 3209
2025
Q1 		$727K Buy
+10,856
New +$648K ﹤0.01% 2036
2020
Q3 		– Sell
-6,726
Closed -$218K – 1268
2020
Q2 		$218K Sell
6,726
-9,713
-59% -$348K 0.01% 998
2020
Q1 		$670K Buy
16,439
+9,661
+143% +$514K 0.06% 376
2019
Q4 		$418K Sell
6,778
-521
-7% -$34.5K 0.02% 774
2019
Q3 		$532K Buy
+7,299
New +$546K 0.02% 696
2017
Q2 		– Sell
-8,300
Closed -$411K – 1022
2017
Q1 		$411K Buy
8,300
+3,700
+80% +$208K 0.01% 799
2016
Q4 		$279K Sell
4,600
-1,900
-29% -$116K 0.01% 1050
2016
Q3 		$431K Buy
+6,500
New +$407K 0.01% 809
2016
Q2 		– Sell
-12,431
Closed -$418K – 1609
2016
Q1 		$418K Buy
12,431
+980
+9% +$33.2K 0.01% 1081
2015
Q4 		$517K Sell
11,451
-5,434
-32% -$234K 0.01% 849
2015
Q3 		$667K Buy
16,885
+9,904
+142% +$563K 0.02% 593
2015
Q2 		$433K Sell
6,981
-5,308
-43% -$316K 0.01% 860
2015
Q1 		$769K Sell
12,289
-2,659
-18% -$162K 0.02% 494
2014
Q4 		$843K Buy
+14,948
New +$659K 0.03% 429

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tudor Investment Corp's ANIP Position: Q1 2026 in Review

Tudor Investment Corp sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 5,509 shares — an estimated $435K sold.

Tudor Investment Corp first reported a position in ANIP in Q4 2014 and held it in 16 quarters. The position peaked at $1.09M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Tudor Investment Corp reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 5,509 ANI Pharmaceuticals shares in Q1 2026, an estimated $435K.
  • Tudor Investment Corp first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 16 quarters.
  • Tudor Investment Corp's ANI Pharmaceuticals position peaked at $1.09M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.